Format

Send to

Choose Destination
Clin Infect Dis. 2005 Nov 15;41(10):1537-40. Epub 2005 Oct 13.

Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs.

Author information

1
Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Chitsanu.P@Chula.ac.th

Abstract

A reduced dose (0.1 mL) of intradermal hepatitis A virus (HAV) vaccine could facilitate the control of hepatitis A in countries of endemicity. All study subjects receiving an aluminum-free HAV vaccine intradermally were seroprotected 28 days after vaccination (anti-HAV titer, > or =10 mIU/mL). Seroprotection rates decreased to 80.8% at 12 months but returned to 100%, with titers increasing 28-fold, after receipt of a booster vaccination.

PMID:
16231271
DOI:
10.1086/497266
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center